JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (5): 81-84.doi: 10.6040/j.issn.1673-3770.0.2016.319

Previous Articles     Next Articles

Obstructive sleep apnea hypopnea syndrome and Fibroblast growth factor 21.

LIANG Xiaohong, LI Yan, LI Chong   

  1. Department of Respiratory, the First Peoples Hospital of Changzhou/the Third affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu, China
  • Received:2016-07-21 Online:2016-10-20 Published:2016-10-20

PDF (PC)

1403

Abstract: The prevalence of OSAHS has been dramatically increasing during the last decade, which has become one of the major diseases that endangers human health. The pathogenesis of OSAHS is not yet fully clear. Some studies have shown that FGF21 is closely linked with OSAHS. The correlation between FGF21 and OSAHS will be discussed in this chapter.

Key words: Fibroblast growth factor 21, Glucose and lipid metabolism, Energy metabolism, Obstructive sleep apnea hypopnea syndrome

CLC Number: 

  • R766.7
[1] Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver[J]. Biochim Biophys Acta, 2000, 1492(1):203-206.
[2] Iglesias P, Selgas R, Romero S, et al. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21[J]. Eur J Endocrinol, 2012, 167(3):301-309.
[3] Nies V J, Sancar G, Liu W, et al. Fibroblast growth factor signaling in metabolic regulation[J]. Front Endocrinol(Lausanne), 2015, 6:193.
[4] Indrakusuma I, Sell H, Eckel J. Novel mediators of adipose tissue and muscle crosstalk[J]. Curr Obes Rep, 2015, 4(4):411-417.
[5] Owen B M, Mangelsdorf D J, Kliewer S A. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21[J]. Trends Endocrinol Metab, 2015, 26(1):22-29.
[6] Zhao Y, Dunbar J D, Kharitonenkov A. FGF21 as a therapeutic reagent[J]. Adv Exp Med Biol, 2012, 728(2):214-228.
[7] So W Y, Leung P S. Fibroblast growth factor 21 as an emerging therapeutic target for Type 2 diabetes mellitus[J]. Med Res Rev, 2016, 36(4):672-704.
[8] Chau M D, Gao J, Yang Q, et al. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway[J]. Proc Natl Acad Sci U S A, 2010, 107(28):12553-12558.
[9] 芮欣忆, 阮晓楠,周先锋,等.上海市浦东新区20~74岁居民超重、肥胖、中心性肥胖的现况调查及流行特征[J].中华内分泌代谢杂志, 2016, 32(3):206-212. RUI Xinyi, RUAN Xiaonan, ZHOU Xianfeng, et al. Prevalence and epidemic characteristic of overweight, obesity, and central obesity in Shanghai Pudong New[J]. Chin J Endocrinol Metab, 2016, 32(3):206-212.
[10] 中华医学会呼吸病学会睡眠呼吸障碍学组,阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志,2012,35(1):9-12. Chinese Medical Association of respiratory disease sleep respiratory disorder group, Clinical Practice Guidelines on traetment of obstructive sleep apnea sydrome[J]. Chin J Tuber Resp Dis, 2012, 35(1):9-12.
[11] Parekh R, Green E, Majeed A. Obstructive sleep apnoea: quantifying its association with obesity and snoring[J]. Prim Care Respir J, 2012, 21(4):361-362.
[12] Romero-Corral A, Caples S M, Lopez-Jimenez F, et al. Interactions between obesity and obstructive sleep apnea: implications for treatment[J]. Chest, 2010, 137(3):711-719.
[13] Giralt M, Gavalda-Navarro A, Villarroya F. Fibroblast growth factor-21, energy balance and obesity[J]. Mol Cell Endocrinol, 2015, 418:66-73.
[14] Fisher F M, Chui P C, Antonellis P J, et al. Obesity is a fibroblast growth factor 21(FGF21)-resistant state[J]. Diabetes, 2010, 59(11):2781-2789.
[15] Reinehr T, Woelfle J, Wunsch R, et al. Fibroblast growth factor 21(FGF-21)and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis[J]. J Clin Endocrinol Metab, 2012, 97(6):2143-2150.
[16] Zhang J, Li Y. Fibroblast growth factor 21 analogs for treating metabolic disorders[J]. Front Endocrinol(Lausanne), 2015, 6:168.
[17] Hui P, Jia S, Ma W, et al. The clinical significance and changes of serum tumor necrosis factor and plasma endothelium in patients with OSAHS associated Type 2 diabetes mellites[J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2016, 30(3):217-219, 225.
[18] Xu J, Long Y S, Gozal D, et al. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress[J]. Free Radic Biol Med, 2009, 46(6):783-790.
[19] Fan H, Sun X, Zhang H, et al. Effect of metformin on fibroblast growth factor-21 levels in patients with newly diagnosed Type 2 diabetes[J]. Diabetes Technol Ther, 2016, 18(3):120-126.
[20] Adams A C, Halstead C A, Hansen B C, et al. LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys[J]. PLoS One, 2013, 8(6):e65763.
[21] Mu J, Pinkstaff J, Li Z, et al. FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents[J]. Diabetes, 2012, 61(2):505-512.
[22] Lin Z, Tian H, Lam K S, et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice[J]. Cell Metab, 2013, 17(5):779-789.
[23] Anker S D, von Haehling S, Germany R. Sleep-disordered breathing and cardiovascular disease[J]. Indian Heart J, 2016, 68(1):69-76.
[24] Cheng P, Zhang F, Yu L, et al. Physiological and pharmacological roles of FGF21 in cardiovascular diseases[J]. J Diabetes Res, 2016, 2016:1540267.
[25] Chow WS, Xu A, Woo YC, et al. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors[J]. Arterioscler Thromb Vasc Biol, 2013, 33(10):2454-2459.
[26] Jin L, Lin Z, Xu A. Fibroblast growth factor 21 protects against atherosclerosis via fine-tuning the multiorgan crosstalk[J]. Diabetes Metab J, 2016, 40(1):22-31.
[27] Lin Z, Pan X, Wu F, et al. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice[J]. Circulation, 2015, 131(21):1861-1871.
[28] Cuevas-Ramos D, Aguilar-Salinas C A. Modulation of energy balance by fibroblast growth factor 21[J]. Horm Mol Biol Clin Investig, 2016.
[29] Hanssen M J, Broeders E, Samms R J, et al. Serum FGF21 levels are associated with brown adipose tissue activity in humans[J]. Sci Rep, 2015, 5:10275.
[30] Takx R, Ishai A, Truong Q A, et al. Supraclavicular Brown adipose tissue FDG uptake and cardiovascular disease[J]. J Nucl Med, 2016, 57(8):1221-1225.
[1] WANG Guifang, LI Rengao, MA Qing. Effects of H-UPPP combined with radiofrequency ablation of tongue root with low temperature plasma on oxygen saturation and arterial oxygen partial pressure in patients with OSAHS [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 49-54.
[2] WANG Lei, LI Baowei, WANG Gang, LIU Hongdan, HAN Haolun, ZHANG Xiaoli, WU Wei. A preliminary study on nocturnal alkali reflux in OSAHS patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 75-79.
[3] YUAN Yuqi, CAO Zine, NIU Xiaoxin, XIE Yushan, SU Yonglong, ZHU Simin, ZHANG Yitong, LIU Haiqin, REN Xiaoyong, SHI Yewen. Clinical significance of peripheral blood inflammatory markers in obstructive sleep apnea hypopnea syndrome with hypertension [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 85-92.
[4] XING Liang, YUAN Yuqi, XIE Yushan, SU Yonglong, NIU Xiaoxin, MA Lina, WANG Zitong, LIU Haiqin, SHI Yewen, REN Xiaoyong. Metabolic markers in obstruetive sleep apnea hypopnea syndrome patients with different arousal thresholds [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 106-111.
[5] DING Longqing, LIU Yiming, CHENG Zhuo, SUN Ran, LIANG Hui. Observation on the therapeutic effect of oropharyngeal exercise on adult obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 153-158.
[6] CHEN Shangli, QIN Tao, CHEN Xuan, CHEN Ruojin, TANG Zhi. Association between homocysteine concentration and the MTHFR C677T polymorphism and hypertension in patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 126-133.
[7] WANG Nan, HUANG Jing, PEN Tao, FENG Bo. Current research on the relationship between obstructive sleep apnea hypopnea syndrome and tinnitus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 122-127.
[8] ZHANG Xiaoxue, WANG Wei, LIU Jie, XU Zhenju, QIAN Yongheng, HAN Min. The bacteriological characteristics and drug sensitivity of the oropharyngeal region in children and adults with OSAHS [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 35-40.
[9] PAN Jianyun, MO KunlanOverview,HU Yuli, LI ChaoyuGuidance. Research progress in internet medical services of CPAP use in patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 117-122.
[10] HAN Yingying,LI Yanzhong. Obstructive sleep apnea hypopnea syndrome and subclinical arteriosclerosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 126-132.
[11] JI Di, DENG Anchun. Meta-analysis of the effect of surgery for obstructive sleep apnea hypopnea syndrome on blood pressure [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 92-98.
[12] LI Xiao, YUAN Ying, LI Yanzhong, WANG Yan, YANG Ke, SUN Yongqiang, YU Xuemin, WANG Ning, WANG Lei. Effects of anxiety and depression on nocturnal blood pressure fluctuation in patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 68-71.
[13] YAN Zhigang, ZHANG Huihui, YU Dan, LIU Yan, WEN Lianji, WANG Di. Diagnosis and treatment of cognitive deficits in adult patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 155-161.
[14] LI Ling, WANG Chunling, ZHANG Li, LI Yanzhong.. Predictors of difficult airway in patients with obstructive sleep apnea-hypopnea syndrome during general anesthesia. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 62-67.
[15] LIU Wenjun, YU Xueying, LÜ Dan, CHEN Zhenggang, ZHANG Yanqing, MEI Xubin, YANG Ke. Correlation between obstructive sleep apnea hypopnea syndrome and upper airway measurements of different genders. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 54-59.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd